Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This study aimed to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels with clinical severity and mortality among hospitalized patients with moderate and severe COVID-19.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This retrospective observational cohort study included adult patients (≥18 years) who were hospitalized with confirmed SARS-CoV-2 infection by polymerase chain reaction (PCR) between March and May 2020.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients

Cohort study · Frontiers in Nutrition · 2026

Original publication title

Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients

Esra Canbolat Unlu; Semsi Nur Karabela; Zuhal Yesilbag; Ramazan Korkusuz; Deniz Borcak; Esra Salim Dogdas; Sevtap Senoglu; Nilgun Isiksacan; Kadriye Kart Yasar

Copyright © 2026 Canbolat Unlu, Karabela, Yesilbag, Korkusuz, Borcak, Salim Dogdas, Senoglu, Isiksacan and Kart Yasar.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Reduced 1,25(OH)2D levels are associated with severe COVID-19 and may serve as a meaningful biomarker for predicting disease severity. These findings suggest that assessing 1,25(OH)2D levels may support clinical decision-making, particularly in patients at risk for severe COVID-19 or ARDS.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

This study aimed to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels with clinical severity and mortality among hospitalized patients with moderate and severe COVID-19.

Source: Background

Abstract: What methods does the paper describe?

A total of 185 adult patients (≥18 years) with confirmed SARS-CoV-2 PCR positivity and without chronic kidney disease, admitted between March and May 2020, were included. Clinical characteristics, laboratory parameters, and serum 25(OH)D and 1,25(OH)2D levels were assessed. Factors associated with severe disease and mortality were determined using multivariate logistic regression and Cox regression analyses.

Source: Methods

Abstract: Results

Of the patients, 114 had moderate disease and 71 had severe disease. Length of hospital stay, intensive care unit (ICU) admission, and mortality rates were significantly higher in the severe group. While 25(OH)D levels were lower in the moderate group, 1,25(OH)2D levels were markedly reduced in severe cases. Multivariate analysis identified prolonged hospital stay, ICU admission history, and low 1,25(OH)2D levels were independently associated with severe disease. Independently associated factors with mortality were ICU admission (p < 0.001), high troponin levels (p = 0.003) and prolonged activated partial thromboplastin time (APTT) (p = 0.04).

Although vitamin D deficiency was associated with severe disease, it was not independently associated with mortality.

Source: Results

Abstract: Conclusion

Reduced 1,25(OH)2D levels are associated with severe COVID-19 and may serve as a meaningful biomarker for predicting disease severity. These findings suggest that assessing 1,25(OH)2D levels may support clinical decision-making, particularly in patients at risk for severe COVID-19 or ARDS.

Source: Conclusion
Authors’ abstract

Background

This study aimed to evaluate the association of serum 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D (1,25(OH)2D) levels with clinical severity and mortality among hospitalized patients with moderate and severe COVID-19.

Methods

A total of 185 adult patients (≥18 years) with confirmed SARS-CoV-2 PCR positivity and without chronic kidney disease, admitted between March and May 2020, were included. Clinical characteristics, laboratory parameters, and serum 25(OH)D and 1,25(OH)2D levels were assessed. Factors associated with severe disease and mortality were determined using multivariate logistic regression and Cox regression analyses.

Results

Of the patients, 114 had moderate disease and 71 had severe disease. Length of hospital stay, intensive care unit (ICU) admission, and mortality rates were significantly higher in the severe group. While 25(OH)D levels were lower in the moderate group, 1,25(OH)2D levels were markedly reduced in severe cases. Multivariate analysis identified prolonged hospital stay, ICU admission history, and low 1,25(OH)2D levels were independently associated with severe disease. Independently associated factors with mortality were ICU admission (p < 0.001), high troponin levels (p = 0.003) and prolonged activated partial thromboplastin time (APTT) (p = 0.04).

Although vitamin D deficiency was associated with severe disease, it was not independently associated with mortality.

Conclusion

Reduced 1,25(OH)2D levels are associated with severe COVID-19 and may serve as a meaningful biomarker for predicting disease severity. These findings suggest that assessing 1,25(OH)2D levels may support clinical decision-making, particularly in patients at risk for severe COVID-19 or ARDS.

Publication and source details

Original title: Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients

Esra Canbolat Unlu; Semsi Nur Karabela; Zuhal Yesilbag; Ramazan Korkusuz; Deniz Borcak; Esra Salim Dogdas; Sevtap Senoglu; Nilgun Isiksacan; Kadriye Kart Yasar

Frontiers in Nutrition · 2026

* Correspondence: Esra Canbolat Unlu, esracanbolat@gmail.com
†

These authors have contributed equally to this work

Copyright © 2026 Canbolat Unlu, Karabela, Yesilbag, Korkusuz, Borcak, Salim Dogdas, Senoglu, Isiksacan and Kart Yasar.2026Canbolat Unlu, Karabela, Yesilbag, Korkusuz, Borcak, Salim Dogdas, Senoglu, Isiksacan and Kart Yasarhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:21:13.593884+00:00

DOI: 10.3389/fnut.2026.1836021 · PMC13279753